FDA draft guidance on companion diagnostics
Posted on Tuesday, August 2, 2011
From the editor:
Two weeks ago, the FDA released a new draft guidance that should be of interest to anyone working in the digital pathology field to or anyone interested in companion diagnostics. It could be even more important to those not interested in companion diagnostics if they are into drug development. I’ll briefly summarize some main points but the draft clearly deserves detailed reading.
